Observational Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Feb 27, 2023; 15(2): 234-248
Published online Feb 27, 2023. doi: 10.4240/wjgs.v15.i2.234
Figure 1
Figure 1 Flow diagram of inclusion and exclusion criteria of the studied patients. IBD: Inflammatory bowel disease; HIV: Human immunodeficiency virus; SLE: Systemic lupus erythematosus; PSC: Primary sclerosing cholangitis.
Figure 2
Figure 2 Hepatobiliary manifestations of the studied patients. PSC: Primary sclerosing cholangitis.; PVT: Portal vein thrombosis.
Figure 3
Figure 3 Laboratory and clinical findings before and after surgery. A: Laboratory findings before and after surgery; B: Clinical findings before and after surgery. ALT: Alanine transaminase; AST: Aaspartate aminotransferase; AKP: Alkaline phosphatase.
Figure 4
Figure 4 The course and outcome of each hepatobiliary manifestations. A: Hepatobiliary manifestations course in the studied patients; B: The outcome for each hepatobiliary manifestation. PSC: Primary sclerosing cholangitis.; PVT: Portal vein thrombosis.
Figure 5
Figure 5 Overall and recurrence-free survival of the studied patients.

  • Citation: Habeeb TAAM, Hussain A, Podda M, Cianci P, Ramshaw B, Safwat K, Amr WM, Wasefy T, Fiad AA, Mansour MI, Moursi AM, Osman G, Qasem A, Fawzy M, Alsaad MIA, Kalmoush AE, Nassar MS, Mustafa FM, Badawy MHM, Hamdy A, Elbelkasi H, Mousa B, Metwalli AEM, Mawla WA, Elaidy MM, Baghdadi MA, Raafat A. Hepatobiliary manifestations following two-stages elective laparoscopic restorative proctocolectomy for patients with ulcerative colitis: A prospective observational study. World J Gastrointest Surg 2023; 15(2): 234-248
  • URL: https://www.wjgnet.com/1948-9366/full/v15/i2/234.htm
  • DOI: https://dx.doi.org/10.4240/wjgs.v15.i2.234